928659-17-0

928659-17-0 structure

Name: Triazavirin
Chemical Name: Riamilovir Sodium Dihydrate
CAS Number: 928659-17-0
Molecular Formula: C₅H₇N₆NaO₅S
Molecular Weight: 286.201
Catalog: Signaling Pathways Anti-infection Influenza Virus
Create Date: 2020-01-11 22:07:01
Modify Date: 2025-08-25 19:43:44
Triazavirin (Riamilovir sodium dihydrate) is a broad-spectrum antiviral agent targeting influenza viruses, lassa virus, TBEV and Ebola virus; suppresses the replication of influenza virus in cell culture and in chicken chorioallantoic membranes, and protects mice from death caused by type A and B influenza viruses.

Name	Riamilovir Sodium Dihydrate
Synonyms	Riamilovir Sodium Dihydrate Sodium 7-(methylsulfanyl)-3-nitro-4-oxo-4H-[1,2,4]triazolo[5,1-c][1,2,4]triazin-1-ide hydrate (1:1:2) [1,2,4]Triazolo[5,1-c][1,2,4]triazin-4(1H)-one, 7-(methylthio)-3-nitro-, sodium salt, hydrate (1:1:2)

Description	Triazavirin (Riamilovir sodium dihydrate) is a broad-spectrum antiviral agent targeting influenza viruses, lassa virus, TBEV and Ebola virus; suppresses the replication of influenza virus in cell culture and in chicken chorioallantoic membranes, and protects mice from death caused by type A and B influenza viruses.
Related Catalog	Signaling Pathways >> Anti-infection >> Influenza Virus Research Areas >> Infection Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog
Target	Nucleoside analogue; Influenza virus[1]
In Vitro	The efficacy of Triazavirin against the tick-borne encephalitis virus is estimated in the sensitive cell culture. In a concentration of 128 mcg/mL Triazavirin is shown active in inhibition of the tick-borne encephalitis virus reproduction (strain Sofiin) by accumulation in the SKEV cell culture[2].
In Vivo	The therapeutic efficacy Triazavirin against experimental Forest-Spring encephalitis on albino mice is studied. The results shows that in high doses (200-400 mg/kg) Triazavirin moderately protects the infected animals. A significant increase of the animal lifespan in the test groups (from 4.1 to 4.8 days) and a statistically valid decrease of the virus accumulation in the target organ are observed[3].
References	[1]. Kozhikhova KV, et al. Preparation of chitosan-coated liposomes as a novel carrier system for the antiviral drug Triazavirin. Pharm Dev Technol. 2018 Apr;23(4):334-342. [2]. Loginova SIa, et al. Investigation of Triazavirin antiviral activity against tick-borne encephalitis pathogen in cell culture. Antibiot Khimioter. 2014;59(1-2):3-5. [3]. Loginova SY, et al. Investigation of Therapeutic Efficacy of Triazavirin Against Experimental Forest-Spring Encephalitis on Albino Mice. Antibiot Khimioter. 2015;60(7-8):11-3.

Molecular Formula	C₅H₇N₆NaO₅S
Molecular Weight	286.201
Exact Mass	286.009644

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

2137764-00-0	2138511-17-6
2137764-07-7	2137652-79-8
2137764-21-5	2137652-82-3
2138511-64-3	2137561-99-8
2137652-87-8	910442-83-0